Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMN Healthcare Services, Inc. (NYSE: AMN) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on AMN Healthcare’s financial condition, capital structure, governance and material events affecting its healthcare workforce solutions and staffing business.
Through periodic and current reports, investors can review how AMN Healthcare’s three reportable segments—Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions—contribute to its overall performance. Filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically include segment discussions, risk factors, management’s analysis and notes on non-GAAP measures like adjusted EBITDA and adjusted diluted EPS.
Current reports on Form 8-K highlight specific events, including earnings announcements, senior notes offerings, amendments to the company’s credit agreement, and changes to its by-laws. For example, AMN Healthcare has filed 8-Ks describing the issuance of senior notes due 2031, amendments to its secured revolving credit facility, and the adoption of amended and restated by-laws that align with developments in Delaware law and update stockholder meeting procedures.
On this page, users can also access filings related to capital markets activities and other material agreements, which explain the terms of AMN Healthcare’s debt instruments and covenants. These disclosures help investors understand the company’s leverage, maturity profiles and financial flexibility.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points in plain language. Users can quickly see the main implications of lengthy documents, such as how a new notes offering affects the balance sheet or how governance changes may influence stockholder rights, while still having the option to review the full SEC filings.
AMN Healthcare’s Chief Legal Officer reported several equity award movements on AMN common stock. On January 15, 2026, restricted stock units vested into common shares, and some shares were withheld at $19.55 per share to cover taxes, leaving 23,652 common shares beneficially owned directly.
The filing also shows activity in restricted stock units. Earlier RSU awards vested into common stock, reducing those RSU balances, while a new grant of 19,641 RSUs was received under the AMN Healthcare 2025 Equity Plan, resulting in 19,641 derivative securities beneficially owned. The amendment corrects a prior filing that had overstated RSU holdings by 19,641 units, clarifying that the correct post‑transaction balance is 19,641, not 39,282.
AMN Healthcare Services CEO Caroline Grace reported multiple equity compensation transactions dated January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were settled into AMN common stock in amounts of 5,042, 10,664, and 25,425 shares, with corresponding common stock entries showing these as acquisitions at $0 per share. The filing notes that these common shares were acquired upon RSU vesting and that some shares, including 1,495, 2,713, and 6,191 shares at $19.55 per share, were withheld to cover taxes.
After the reported transactions, Grace directly beneficially owned 81,686 shares of AMN common stock, which includes 607 shares acquired through the employee stock purchase plan. She also received a new RSU grant covering 129,923 units, all directly held, each representing a contingent right to one share of common stock and vesting in three annual tranches beginning on the grant date.
AMN Healthcare Services Inc. Chief Legal Officer Whitney M. Laughlin reported equity award activity dated January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into shares of AMN common stock, with portions of the resulting shares withheld to cover taxes at a price of $19.55 per share.
The filing shows RSU conversions of 202, 749 and 3,537 units into common stock, paired with tax withholdings of 60, 223 and 1,049 shares, respectively. Following these transactions, Laughlin held 23,652 shares of AMN common stock directly.
On the same date, Laughlin received a new grant of 19,641 RSUs under the AMN Healthcare 2025 Equity Plan, each unit representing a right to receive one share of common stock. After this grant, Laughlin beneficially owned 39,282 RSUs, which vest in three annual tranches starting from their respective grant dates.
AMN Healthcare Services executive Mark Christopher Hagan, Chief Information and Digital officer, reported multiple equity compensation transactions on January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into common stock, including 1,433, 2,248, and 6,632 shares of AMN common stock. To cover taxes, the company withheld 591, 926, and 2,622 shares at a price of $19.55 per share.
On the same date, Hagan received a new grant of 36,828 RSUs under the AMN Healthcare 2025 Equity Plan, each representing a right to one share of common stock. After these transactions, he directly owned 44,873 shares of AMN common stock and held 73,656 RSUs. The RSUs granted on January 15 of 2023, 2024, 2025, and 2026 all vest in three annual tranches tied to continued service.
AMN Healthcare Services CFO/COO Brian M. Scott reported equity compensation activity on January 15, 2026. He acquired 8,843 shares of common stock at $0 upon vesting of Restricted Stock Units and then had 3,592 shares of common stock withheld at $19.55 per share to cover taxes, leaving him with 13,093 shares of common stock held directly.
On the derivative side, 8,843 Restricted Stock Units were converted into common stock, after which he held 17,956 Restricted Stock Units from an award granted under the AMN Healthcare 2017 Equity Plan that vests over three years. He also received a new grant of 40,920 Restricted Stock Units under the AMN Healthcare 2025 Equity Plan, bringing his total Restricted Stock Units to 81,840, each representing a contingent right to one share of AMN common stock and vesting in three annual tranches.
AMN Healthcare Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026. The company has prepared a slide presentation for this event, which is attached as Exhibit 99.1 and will also be available through the Investor Relations section of its website at https://ir.amnhealthcare.com/.
The information related to this conference appearance is being furnished under Item 7.01 and is not deemed filed under securities laws, meaning it will only be incorporated into other documents by specific reference. The report is signed on behalf of the company by Chief Executive Officer Cary Grace.
AMN Healthcare Services Inc executive Brian M. Scott, the company's CFO/COO, reported the vesting of restricted stock units into 12,212 shares of common stock on December 15, 2025. These shares were acquired at $0 per share as the units converted.
On the same date, 4,370 shares were disposed of at $16.37 per share to cover tax obligations, leaving Scott with 7,842 common shares held directly. He also holds 24,797 restricted stock units granted on December 15, 2024 under the AMN Healthcare 2017 Equity Plan, which vest on the first, second and third anniversaries of the grant date, with each unit representing one share of AMN common stock and no expiration date.
AMN Healthcare Services, Inc. reported that its Board of Directors approved amended and restated by-laws, effective immediately on December 11, 2025. The changes are designed to align its governance rules with current Delaware law and to tighten and clarify procedures around how stockholders call special meetings and bring business before meetings.
The updated by-laws refine the information and disclosure that stockholders must provide when nominating directors or submitting proposals, and they clarify the authority of the Board and the meeting chair to manage conduct at stockholder meetings. They also require director candidates to be available for interviews with Board members about their qualifications, while making additional ministerial and conforming updates.
AMN Healthcare Services (AMN) received a Schedule 13G from investors affiliated with Millennium. Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 2,446,024 shares of common stock, representing 6.4% of the class, with shared voting and dispositive power over those shares and no sole power. Integrated Core Strategies (US) LLC reported beneficial ownership of 2,425,686 shares, representing 6.3% of the class, also with shared voting and dispositive power and no sole power.
The filers certified the securities were not acquired and are not held for the purpose of changing or influencing control of AMN. The filing relates to AMN’s common stock, par value $0.01 per share, and lists a Date of Event of 11/04/2025.
AMN Healthcare Services (AMN) filed its Q3 2025 report, showing revenue of $634.5 million, down from $687.5 million a year ago. Net income rose to $29.3 million from $7.0 million, with diluted EPS of $0.76 versus $0.18.
Year to date, revenue was $1,982.2 million versus $2,249.1 million, and the company reported a net loss of $88.0 million, primarily reflecting a non-cash goodwill impairment of $109.5 million and a $18.3 million long‑lived asset impairment recorded earlier in the year. Q3 included a $39.2 million gain on the sale of the Smart Square scheduling software, for which AMN received $65.3 million in cash and a $10.0 million 9.000% promissory note due January 1, 2027.
Operating cash flow reached $193.9 million for the nine months. Cash and cash equivalents were $52.6 million, and total stockholders’ equity was $644.4 million at September 30, 2025. Segment Q3 revenue: Nurse & Allied $361.5 million, Physician & Leadership $178.2 million, Technology & Workforce $94.8 million.
Subsequent events: On October 6, 2025, AMN issued $400.0 million of 6.500% senior notes due 2031 and amended its credit facility (maturity extended to October 6, 2030; revolving commitments set at $450.0 million; leverage covenant updated). On October 22, 2025, it redeemed the $500.0 million 2027 notes using note proceeds, revolver borrowings, and operating cash.